Category Specific RSS

Chris Lotsaris

Bubs goes full steam ahead with US FDA trials in rising market for infant formula

Baby formula and food company Bubs Australia (ASX: BUB) spent a large part of FY23 undertaking reputation management as its…

2 years ago